A Double-Blind, Placebo-Controlled, Parallel-Group, Study of Rufinamide Given as Adjunctive Therapy in Patients with Refractory Partial Seizures

Grants and Contracts Details

StatusFinished
Effective start/end date5/10/074/30/11

Funding

  • Eisai Incorporated: $48,220.00